Literature DB >> 17391392

Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples.

C Gagliotti1, L Nobilio, M L Moro.   

Abstract

This study investigated the association between prescription of fluoroquinolones and emergence of ciprofloxacin resistance among Escherichia coli isolates in the urine of outpatients from whom a ciprofloxacin-sensitive E. coli strain had been isolated previously. Patients were identified and followed using the healthcare databases of Emilia-Romagna Region, Italy. The outcome of interest was the first isolation from urine of an E. coli strain resistant to ciprofloxacin. Prescription of fluoroquinolones during the previous 6 months was associated independently with the emergence of ciprofloxacin resistance; the strength of the association varied according to individual fluoroquinolone agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391392     DOI: 10.1111/j.1469-0691.2006.01615.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.

Authors:  L G Smyth; D W Mulvin
Journal:  Ir J Med Sci       Date:  2011-11-06       Impact factor: 1.568

2.  Results of a Multicenter Population Pharmacokinetic Study of Ciprofloxacin in Children with Complicated Urinary Tract Infection.

Authors:  Kevin Meesters; Robin Michelet; Reiner Mauel; Ann Raes; Jan Van Bocxlaer; Johan Vande Walle; An Vermeulen
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.

Authors:  L Blaettler; D Mertz; R Frei; L Elzi; A F Widmer; M Battegay; U Flückiger
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

4.  Antimicrobial resistance in eight US hospitals along the US-Mexico border, 2000-2006.

Authors:  S R Benoit; K D Ellingson; S H Waterman; M L Pearson
Journal:  Epidemiol Infect       Date:  2013-12-17       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.